A Study in Healthy People to Measure the Amount of BI 655130 in the Blood After Injecting Different Doses Into Different Parts of the Body
Clinical trial NCT03617835 · COMPLETED
Trial details
- NCT number
- NCT03617835
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-16
- Primary completion
- 2019-06-03
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.